← Back to patent-cliff list
BSDO-2301
Tier C — Watch / tradeBSDO-2301
Hyundai Pharmaceutical Co Ltd
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：Updating
Indications (approved)：Cardiac and vascular disorders
Regional status
US
-
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of BSDO-2301?
Approved indications include: Cardiac and vascular disorders.
When does the BSDO-2301 patent expire?
No public expiry year is available for BSDO-2301 yet; this page updates once verified.
How do I get a quote for BSDO-2301 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-29